Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01994317 · ClinicalTrials.gov registry record · NA

Use of an Algorithm to Determine IV Sedation Dosing During First-trimester Surgical Abortion

A NA study of Pregnancy, Unplanned, sponsored by Planned Parenthood League of Massachusetts.

Completed
Registry status
NA
Development phase
196
Enrollment target
1
Study location

NCT01994317 is a NA study of Pregnancy, Unplanned that has completed, run by Planned Parenthood League of Massachusetts. The registered enrollment target is 196 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01994317, a NA study of Pregnancy, Unplanned, has completed, sponsored by Planned Parenthood League of Massachusetts.

COMPLETED
Registry status
NA
Development phase
196 participants
Enrollment target
1
Study location

Study Summary

This study aims to compare an algorithm for IV sedation dosing to the current standard of care in patients undergoing first trimester surgical abortion. The primary outcome is subjects' pain score with suction curettage on a 0-100 21-point scale. Secondary outcomes include pain scores with cervical dilation and 15 minutes post-procedure, subjective pain ratings, incidents of side effects and adverse events, the frequency of additional doses of medication, recovery room time, and physician assessment of and satisfaction with pain control. Investigators hypothesize that this algorithm will result in improved pain control, decreased frequency of additional medication doses, improved patient and physician satisfaction, without differences in side effects, adverse events or recovery room time.

Conditions Studied

Interventions

  • OTHER Standard care
  • OTHER Algorithm

Study Locations (1)

Massachusetts

  • Planned Parenthood - Boston

Trial Details

FieldValue
Enrollment Target 196 participants
Start Date 2013-11
Est. Completion 2015-07
Phase NA

What the Registry Record Tells You About NCT01994317

The ClinicalTrials.gov registry entry for NCT01994317 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Planned Parenthood League of Massachusetts, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pregnancy, Unplanned appearing as the primary indexed condition, and to 2 interventions - of which Standard care is the first listed.

NCT01994317 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01994317 about?

NCT01994317 is a clinical study titled "Use of an Algorithm to Determine IV Sedation Dosing During First-trimester Surgical Abortion". This study aims to compare an algorithm for IV sedation dosing to the current standard of care in patients undergoing first trimester surgical abortion. The primary outcome is subjects' pain score with suction curettage on a 0-100 21-point scale. Secondary outcomes include pain scores with cervical ...

What is the current status of trial NCT01994317?

This trial is currently completed. It is a NA study. The enrollment target is 196 participants. The study started on 2013-11. Estimated completion is 2015-07.

What conditions does trial NCT01994317 study?

This clinical trial studies the following conditions: Pregnancy, Unplanned.

What interventions are being tested in trial NCT01994317?

The interventions under investigation include: Standard care (OTHER), Algorithm (OTHER).

Who is sponsoring clinical trial NCT01994317?

This trial is sponsored by Planned Parenthood League of Massachusetts, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01994317 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.